VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Mondelez International, Inc. vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Mondelez International, Inc.
MDLZ · Nasdaq Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Mondelez International, Inc.'s moat claims, evidence, and risks.
View MDLZ analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 66 / 100 for Mondelez International, Inc.).
- Segment focus: Mondelez International, Inc. has 5 segments (48.9% in Biscuits & Baked Snacks); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: Mondelez International, Inc. has 4 moat types across 3 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Mondelez International, Inc.
Biscuits & Baked Snacks
Branded biscuits, cookies, crackers and baked snacks
Global
Consumer (via retail and e-commerce)
Branded manufacturer
48.9%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Mondelez International, Inc. strengths
Novo Nordisk A/S strengths
Segment mix
Mondelez International, Inc. segments
Full profile >Biscuits & Baked Snacks
Oligopoly
Chocolate
Oligopoly
Gum & Candy
Oligopoly
Beverages
Competitive
Cheese & Grocery
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.